Format

Send to

Choose Destination
AJR Am J Roentgenol. 2015 Sep;205(3):W366-73. doi: 10.2214/AJR.15.14534. Epub 2015 Jun 23.

Vascular Imaging With Ferumoxytol as a Contrast Agent.

Author information

1
1 All authors: Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Box 0628, San Francisco, CA 94143-0628.

Abstract

OBJECTIVE:

Ferumoxytol is increasingly reported as an alternative to gadolinium-based contrast agents for MR angiography (MRA), particularly for patients with renal failure. This article summarizes more than 3 years of clinical experience with ferumoxytol-enhanced MRA for a range of indications and anatomic regions.

CONCLUSION:

Ferumoxytol-enhanced MRA has many advantages including that it is safe for patients with renal failure and provides a lengthy plateau of vascular signal as a blood pool agent that allows longer navigated MRA sequences.

KEYWORDS:

4D flow; MR angiography (MRA); contrast agents; ferumoxytol; inflammation; navigated MRA; ultrasmall superparamagnetic iron oxide (USPIO)

PMID:
26102308
PMCID:
PMC5130335
DOI:
10.2214/AJR.15.14534
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center